Monitors show stable vitals. No alerts. The ICU sees a patient who appears fine.
Beneath the surface, organs are silently deteriorating. Without continuous biochemical monitoring, this goes unseen until it is too late.
between ICU biochemical measurements. Heart rate, SpO2, blood pressure: tracked continuously. But biochemistry, the earliest signal of organ failure, depends on a blood draw sent to a lab. Results take hours. In those hours, organ biochemistry is invisible. No device provides continuous biochemical sensing at the bedside.
Ventilators, infusion pumps, CRRT machines, pulse oximeters. Each generates data on its own screen. A nurse manually reads and charts values from separate displays. No device aggregates them into a unified, real-time patient state.
No device in the history of intensive care has computed individual organ trajectories in real time. Vitals monitors display heart rate and oxygen saturation. They cannot tell you: "This patient's kidneys are 4 hours from irreversible damage." The data exists across those devices. The computation has never been performed. PriyAI Sentinel will be the first.
The collision point: the moment where an organ's rate of decline meets a drug's therapeutic onset. This is the most critical timing decision in intensive care. Today it is governed by rigid clinical protocols written years ago and clinical intuition built over decades of experience. No device has ever computed it. PriyAI Sentinel will.
One intensivist managing 8 to 12 patients. Over 1,300 data points reviewed per patient evaluation. Across a full caseload, that is 15,000+ data points in simultaneous flux. The optimum human cognitive capacity is five facts per decision. This is a structural impossibility.
Antibiotics clear infection but destroy kidneys. Fluid restores blood pressure but causes pulmonary edema. Sedation enables ventilation but masks neurological decline. Every intervention saves one organ while risking another. The damage is discovered 12 to 24 hours later. After it compounds.
Clinical protocols dictate reassessment at fixed intervals. Vital sign checks every 15 to 60 minutes. Lactate re-evaluation every 6 hours. Organ function scores every 48 hours. Disease evolves minute by minute. Protocols were written for populations. Your patient is an individual in crisis.
35 years of ICU monitoring. And still, no device sees the whole patient. Continuously. In real time. Until now.
Sentinel™
A bedside device that continuously monitors biochemistry through microfluidic ingestion, aggregates data from every ICU device connected to the patient, computes individual organ trajectories in real time, and predicts the exact intervention window remaining for each organ system.
Hardware + Software + Framework
Industrial Design Render · Iteration 2.1 · Engineered for Bedside Microfluidic Integration
ICU biomarkers arrive every 6 to 24 hours via blood draws. Between measurements, the patient is invisible. KAE converts sporadic lab values into continuous organ trajectories by adapting its own trust in each sensor in real time. Inside PriyAI Sentinel, KAE operates on continuous biochemical data from the device's microfluidic sensing layer. When lab data arrives, KAE fuses it with the device's continuous stream, correcting drift in real time. No manual recalibration. No blind spots.
Every drug has an onset delay. Every organ has a deterioration velocity. MOISS computes whether the drug will reach therapeutic concentration before the organ crosses the point of irreversible damage. MOISS models each organ system as a body in a potential field, fed by aggregated data from every device connected to the patient: ventilators, CRRT machines, infusion pumps, and PriyAI Sentinel's own biochemical sensors. Stable organs orbit near center. Deteriorating organs spiral outward toward the critical boundary.
MOISSCode is a biomedical domain-specific language purpose-built for ICU decision support. 20 specialized modules covering pharmacokinetics, biochemistry, clinical scoring, genomics, device I/O, and more. Clinical protocols execute as machine logic inside the gravitational vortex at 1 Hz. Clinicians do not write code. The device runs it.
Aethryva connects industries that were never connected before.
One platform. Nine industries. Continuous organ trajectory intelligence creating value from ICU bedside to battlefield triage, from actuarial modelling to drug discovery.
EXPLORE THE NETWORKEvery organ trajectory is computed. Every drug onset is modelled. Every collision point is predicted. Continuously. Across ten organ systems. At the bedside. In real time.
PriyAI Sentinel is the first device that reads a patient’s biochemistry continuously, maps real-time organ trajectories across ten systems, and computes the exact intervention window before irreversible damage begins.